ARV
0.004
33.3%
PEN
0.27
-26%
MRQ
0.004
33.3%
CDE
0.007
-22.2%
VAR
0.004
33.3%
ADX
0.019
-20.8%
MYE
0.45
32.4%
SLD
0.43
-18.1%
AXN
0.032
28%
MDI
0.014
-17.6%
DBO
0.014
27.3%
MNB
0.024
-17.2%
AUA
0.038
26.7%
IDT
0.034
-17.1%
EVR
0.005
25%
HTG
0.01
-16.7%
OSX
0.005
25%
CCA
0.054
-14.3%
HMG
0.155
24%
VBS
0.15
-14.3%
PIQ
0.185
23.3%
QGL
0.305
-14.1%
CMD
0.027
22.7%
HFR
0.019
-13.6%
CCE
0.245
22.5%
DRE
0.013
-13.3%
LEX
0.12
20%
AAL
0.245
-12.5%
MML
0.012
20%
M96
0.007
-12.5%
WEC
0.18
20%
PLC
0.007
-12.5%
SGA
0.085
18.1%
RWD
0.03
-11.8%
FAL
0.43
17.8%
PFT
0.023
-11.5%
EMH
0.235
17.5%
APC
0.008
-11.1%
EPM
0.014
16.7%
ATC
0.008
-11.1%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

EZZ Life Science (ASX: EZZ): Targets US expansion followingFDA product approvals

Australian genomic life science company EZZ Life Science (ASX: EZZ) has won approval from the United States (US) Food and Drug Administration (FDA) for nine of its products in the food category, presenting a significant US expansion opportunity for EZZ. | ASX announcement: https://announcements.asx.com.au/asxpdf/20240625/pdf/064x2fh3lh72px.pdf